Tapewire

NYSE · USD

ZTS

Zoetis Inc.

Export transactions ↓
Tapewire entity
679
SEC CIK
0001555280
Parsed reports
1,182

Last 12 months

Inside the activity.

3 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202630
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 23, 2018 Filed Feb 26, 2018 21:32 UTC
Knupp Catherine A.Executive Vice President
SaleCommon Stock 42,796 $82.13 $3,514,835.48
Disclosure

SEC source: 0001555280-18-000089 · wf-form4_151968070874746.xml · nonDerivative · entry 2

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,415

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.10 to $82.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 23, 2018 Filed Feb 26, 2018 21:32 UTC
Knupp Catherine A.Executive Vice President
Exercise / conversionCommon Stock 42,796 $26.00 $1,112,696.00
Disclosure

SEC source: 0001555280-18-000089 · wf-form4_151968070874746.xml · nonDerivative · entry 1

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,211

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 22, 2018 Filed Feb 23, 2018 21:43 UTC
Bernal AlejandroExecutive Vice President
SaleCommon Stock 9,454 $81.00 $765,774.00
Disclosure

SEC source: 0001555280-18-000087 · wf-form4_151942217022815.xml · nonDerivative · entry 4

Bernal Alejandro · CIK 0001567825 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,310

F2 · price: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.

Read SEC document
February 21, 2018 Filed Feb 23, 2018 21:36 UTC
PECK KRISTIN CExecutive Vice President
Exercise / conversionStock Option · Derivative 32,000 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000085 · wf-form4_151942176038993.xml · derivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,158

Underlying: Common Stock · 32,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 32,000 options granted January 31, 2013 at an exercise price of $26.00 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 47,885 options granted January 31, 2013 at an exercise price of $26.00 per option; 78,651 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
February 21, 2018 Filed Feb 23, 2018 21:36 UTC
PECK KRISTIN CExecutive Vice President
SaleCommon Stock 32,000 $81.24 $2,599,680.00
Disclosure

SEC source: 0001555280-18-000085 · wf-form4_151942176038993.xml · nonDerivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,530

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.06 to $81.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Total shares of common stock owned excludes six shares mistakenly included in the total reported in Table I, Column 5 in a Form 4 filed on November 23, 2016.

Read SEC document
February 21, 2018 Filed Feb 23, 2018 21:36 UTC
PECK KRISTIN CExecutive Vice President
Exercise / conversionCommon Stock 32,000 $26.00 $832,000.00
Disclosure

SEC source: 0001555280-18-000085 · wf-form4_151942176038993.xml · nonDerivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,530

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 21, 2018 Filed Feb 23, 2018 21:43 UTC
Bernal AlejandroExecutive Vice President
Exercise / conversionStock Option · Derivative 28,089 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000087 · wf-form4_151942217022815.xml · derivative · entry 6

Bernal Alejandro · CIK 0001567825 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,029

Underlying: Common Stock · 28,089 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F8 · derivative.exercise_price: 28,089 options granted March 4, 2014 at an exercise price of $30.89 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F9 · balance_after: 15,709 options granted February 27, 2015 at an exercise price of $46.09 per option; 22,341 options granted February 19, 2016 at an exercise price of $41.83 per option; and 20,979 options granted February 14, 2017 at an exercise price of $55.02 per option.

Read SEC document
February 21, 2018 Filed Feb 23, 2018 21:43 UTC
Bernal AlejandroExecutive Vice President
Exercise / conversionStock Option · Derivative 32,097 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000087 · wf-form4_151942217022815.xml · derivative · entry 5

Bernal Alejandro · CIK 0001567825 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,118

Underlying: Common Stock · 32,097 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F4 · derivative.exercise_price: 32,097 options granted January 31, 2013 at an exercise price of $26.00 per option.

F5 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F6 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 28,089 options granted March 4, 2014 at an exercise price of $30.89 per option; 15,709 options granted February 27, 2015 at an exercise price of $46.09 per option; 22,341 options granted February 19, 2016 at an exercise price of $41.83 per option; and 20,979 options granted February 14, 2017 at an exercise price of $55.02 per option.

Read SEC document
February 21, 2018 Filed Feb 23, 2018 21:43 UTC
Bernal AlejandroExecutive Vice President
SaleCommon Stock 60,186 $81.18 $4,885,899.48
Disclosure

SEC source: 0001555280-18-000087 · wf-form4_151942217022815.xml · nonDerivative · entry 3

Bernal Alejandro · CIK 0001567825 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,764

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 21, 2018 Filed Feb 23, 2018 21:43 UTC
Bernal AlejandroExecutive Vice President
Exercise / conversionCommon Stock 28,089 $30.89 $867,669.21
Disclosure

SEC source: 0001555280-18-000087 · wf-form4_151942217022815.xml · nonDerivative · entry 2

Bernal Alejandro · CIK 0001567825 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,950

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 21, 2018 Filed Feb 23, 2018 21:43 UTC
Bernal AlejandroExecutive Vice President
Exercise / conversionCommon Stock 32,097 $26.00 $834,522.00
Disclosure

SEC source: 0001555280-18-000087 · wf-form4_151942217022815.xml · nonDerivative · entry 1

Bernal Alejandro · CIK 0001567825 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,861

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 21, 2018 Filed Feb 23, 2018 21:37 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionStock Option · Derivative 35,663 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000086 · wf-form4_151942186134235.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,113

Underlying: Common Stock · 35,663 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 35,663 options granted January 31, 2013 at an exercise price of $26.00 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 37,453 options granted March 4, 2014 at an exercise price of $30.89 per option; 17,852 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; and 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
February 21, 2018 Filed Feb 23, 2018 21:37 UTC
Lagano RoxanneExecutive Vice President
SaleCommon Stock 35,663 $81.02 $2,889,416.26
Disclosure

SEC source: 0001555280-18-000086 · wf-form4_151942186134235.xml · nonDerivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,256

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.00 to $81.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 21, 2018 Filed Feb 23, 2018 21:37 UTC
Lagano RoxanneExecutive Vice President
Exercise / conversionCommon Stock 35,663 $26.00 $927,238.00
Disclosure

SEC source: 0001555280-18-000086 · wf-form4_151942186134235.xml · nonDerivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,919

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 20, 2018 Filed Feb 21, 2018 22:02 UTC
Trawicki RomanExecutive Vice President
SaleCommon Stock 3,804 $80.32 $305,537.28
Disclosure

SEC source: 0001555280-18-000079 · wf-form4_151925056440872.xml · nonDerivative · entry 1

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.32 to $80.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 20, 2018 Filed Feb 21, 2018 21:58 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionStock Option · Derivative 37,453 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000078 · wf-form4_151925029809532.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,516

Underlying: Common Stock · 37,453 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The option vests on the third anniversary of the date of grant.

F3 · derivative.exercise_price: 37,453 options granted March 4, 2014 at an exercise price of $30.89 per option.

F4 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F5 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F6 · balance_after: 22,850 options granted February 27, 2015 at an exercise price of $46.09 per option; 28,299 options granted February 19, 2016 at an exercise price of $41.83 per option; 24,475 options granted February 14, 2017 at an exercise price of $55.02 per option; and 18,892 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
February 20, 2018 Filed Feb 21, 2018 21:58 UTC
Chen Heidi C.Executive Vice President
SaleCommon Stock 37,453 $81.02 $3,034,442.06
Disclosure

SEC source: 0001555280-18-000078 · wf-form4_151925029809532.xml · nonDerivative · entry 2

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,162

F1 · price: The Price reported in Table I, Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.01 to $81.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 20, 2018 Filed Feb 21, 2018 21:58 UTC
Chen Heidi C.Executive Vice President
Exercise / conversionCommon Stock 37,453 $30.89 $1,156,923.17
Disclosure

SEC source: 0001555280-18-000078 · wf-form4_151925029809532.xml · nonDerivative · entry 1

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,615

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 22:10 UTC GrantRestricted Stock Unit · Derivative 2,730 $73.24 $199,945.20
Disclosure

SEC source: 0001555280-18-000069 · wf-form4_151873261889729.xml · derivative · entry 1

MCCALLISTER MICHAEL B · CIK 0001018657 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,285.2521

Underlying: Common Stock · 2,730 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 3,771.0600 RSUs will vest on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 17:23 UTC GrantRestricted Stock Unit · Derivative 2,730 $73.24 $199,945.20
Disclosure

SEC source: 0001555280-18-000075 · wf-form4_151873318008704.xml · derivative · entry 1

STEERE WILLIAM C JR · CIK 0001033870 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,285.2521

Underlying: Common Stock · 2,730 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 3,771.0600 RSUs will vest on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 17:14 UTC GrantRestricted Stock Unit · Derivative 2,730 $73.24 $199,945.20
Disclosure

SEC source: 0001555280-18-000072 · wf-form4_151873287124195.xml · derivative · entry 1

Reed Willie M · CIK 0001601695 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,285.2521

Underlying: Common Stock · 2,730 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 3,771.0600 RSUs will vest on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:53 UTC
PECK KRISTIN CExecutive Vice President
GrantPerformance Award Unit · Derivative 14,035.1334 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000063 · wf-form4_151873160050796.xml · derivative · entry 3

PECK KRISTIN C · CIK 0001488267 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,035.1334

Underlying: Common Stock · 14,035.1334 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2015-2017 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 13, 2018, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:53 UTC
PECK KRISTIN CExecutive Vice President
GrantStock Option · Derivative 24,642 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000063 · wf-form4_151873160050796.xml · derivative · entry 2

PECK KRISTIN C · CIK 0001488267 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 293,158

Underlying: Common Stock · 24,642 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 79,885 options granted January 31, 2013 at an exercise price of $26.00 per option; 78,651 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 79,885 options granted January 31, 2013 at an exercise price of $26.00 per option; 78,651 options granted March 4, 2014 at an exercise price of $30.89 per option; 37,132 options granted February 27, 2015 at an exercise price of $46.09 per option; 40,214 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:53 UTC
PECK KRISTIN CExecutive Vice President
GrantRestricted Stock Unit · Derivative 6,826 $73.24 $499,936.24
Disclosure

SEC source: 0001555280-18-000063 · wf-form4_151873160050796.xml · derivative · entry 1

PECK KRISTIN C · CIK 0001488267 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,894.4057

Underlying: Common Stock · 6,826 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 9,612.7270 RSUs will vest on February 27, 2018; 10,916.5530 RSUs will vest on February 19, 2019; 8,539.1257 RSUs will vest on February 14, 2020; and 6,826 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 17:11 UTC GrantRestricted Stock Unit · Derivative 2,730 $73.24 $199,945.20
Disclosure

SEC source: 0001555280-18-000070 · wf-form4_151873270118686.xml · derivative · entry 1

Norden Gregory · CIK 0001405104 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,285.2521

Underlying: Common Stock · 2,730 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 3,771.0600 RSUs will vest on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 22:17 UTC GrantRestricted Stock Unit · Derivative 2,730 $73.24 $199,945.20
Disclosure

SEC source: 0001555280-18-000074 · wf-form4_151873304347939.xml · derivative · entry 1

SCULLY ROBERT W · CIK 0001352881 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,285.2521

Underlying: Common Stock · 2,730 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 3,771.0600 RSUs will vest on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 22:04 UTC
Bisaro PaulDirector
GrantRestricted Stock Unit · Derivative 2,730 $73.24 $199,945.20
Disclosure

SEC source: 0001555280-18-000065 · wf-form4_151873224243061.xml · derivative · entry 1

BISARO PAUL · CIK 0001237253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,403.0659

Underlying: Common Stock · 2,730 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 3,888.8738 RSUs will vest on May 1, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 22:13 UTC GrantRestricted Stock Unit · Derivative 2,730 $73.24 $199,945.20
Disclosure

SEC source: 0001555280-18-000071 · wf-form4_151873280016043.xml · derivative · entry 1

PARENT LOUISE M · CIK 0001209456 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,285.2521

Underlying: Common Stock · 2,730 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 3,771.0600 RSUs will vest on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 22:05 UTC GrantRestricted Stock Unit · Derivative 2,730 $73.24 $199,945.20
Disclosure

SEC source: 0001555280-18-000066 · wf-form4_151873232301805.xml · derivative · entry 1

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,285.2521

Underlying: Common Stock · 2,730 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 3,771.0600 RSUs will vest on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 17:15 UTC
Rhodes LindaDirector
GrantRestricted Stock Unit · Derivative 2,730 $73.24 $199,945.20
Disclosure

SEC source: 0001555280-18-000073 · wf-form4_151873294289251.xml · derivative · entry 1

Rhodes Linda · CIK 0001336284 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,951.1536

Underlying: Common Stock · 2,730 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 3221.1536 RSUs will vest on August 3, 2020; and 2,730 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 17:09 UTC GrantRestricted Stock Unit · Derivative 2,730 $73.24 $199,945.20
Disclosure

SEC source: 0001555280-18-000068 · wf-form4_151873254939300.xml · derivative · entry 1

Sanjay Khosla · CIK 0001387531 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,285.2521

Underlying: Common Stock · 2,730 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 3,771.0600 RSUs will vest on February 27, 2018; 4,124.2792 RSUs will vest on February 19, 2019; 3,659.9129 RSUs will vest on February 14, 2020; and 2,730 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 16:40 UTC
Fenton AndrewExecutive Vice President
GrantPerformance Award Unit · Derivative 4,856.9778 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000060 · wf-form4_151873078704671.xml · derivative · entry 3

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,856.9778

Underlying: Common Stock · 4,856.9778 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2015-2017 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 13, 2018, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 16:40 UTC
Fenton AndrewExecutive Vice President
GrantStock Option · Derivative 13,142 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000060 · wf-form4_151873078704671.xml · derivative · entry 2

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,477

Underlying: Common Stock · 13,142 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 12,853 options granted February 27, 2015 at an exercise price of $46.09 per option; 14,149 options granted February 19, 2016 at an exercise price of $41.83 per option; 3,872 options granted August 22, 2016 at an exercise price of $51.32 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; and 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 12,853 options granted February 27, 2015 at an exercise price of $46.09 per option; 14,149 options granted February 19, 2016 at an exercise price of $41.83 per option; 3,872 options granted August 22, 2016 at an exercise price of $51.32 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; and 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 16:40 UTC
Fenton AndrewExecutive Vice President
GrantRestricted Stock Unit · Derivative 3,640 $73.24 $266,593.60
Disclosure

SEC source: 0001555280-18-000060 · wf-form4_151873078704671.xml · derivative · entry 1

Fenton Andrew · CIK 0001538226 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,075.3014

Underlying: Common Stock · 3,640 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 3,327.2858 RSUs will vest on February 27, 2018; 3,841.1410 RSUs will vest on February 19, 2019; 985.5012 RSUs will vest on August 22, 2019; 3,012.3140 RSUs will vest on December 6, 2019; 4,269.0594 RSUs will vest on February 14, 2020; and 3,640 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 22:02 UTC
Trawicki RomanExecutive Vice President
GrantPerformance Award Unit · Derivative 3,237.3036 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000064 · wf-form4_151873208706036.xml · derivative · entry 3

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,237.3036

Underlying: Common Stock · 3,237.3036 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2015-2017 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 13, 2018, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 22:02 UTC
Trawicki RomanExecutive Vice President
GrantStock Option · Derivative 13,142 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000064 · wf-form4_151873208706036.xml · derivative · entry 2

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 84,473

Underlying: Common Stock · 13,142 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 23,885 options granted January 30, 2015 at an exercise price of $42.73 per option; 8,568 options granted February 27, 2015 at an exercise price of $46.09 per option; 4,688 options granted July 21, 2015 at an exercise price of $49.12 per option; 17,873 options granted February 19, 2016 at an exercise price of $41.83 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; and 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 23,885 options granted January 30, 2015 at an exercise price of $42.73 per option; 8,568 options granted February 27, 2015 at an exercise price of $46.09 per option; 4,688 options granted July 21, 2015 at an exercise price of $49.12 per option; 17,873 options granted February 19, 2016 at an exercise price of $41.83 per option; 16,317 options granted February 14, 2017 at an exercise price of $55.02 per option; and 13,142 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 22:02 UTC
Trawicki RomanExecutive Vice President
GrantRestricted Stock Unit · Derivative 3,640 $73.24 $266,593.60
Disclosure

SEC source: 0001555280-18-000064 · wf-form4_151873208706036.xml · derivative · entry 1

Trawicki Roman · CIK 0001640777 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,277.1559

Underlying: Common Stock · 3,640 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 2,217.8497 RSUs will vest on February 27, 2018; 1,298.3327 RSUs will vest on July 21, 2018; 4,851.9141 RSUs will vest on February 19, 2019; 4,269.0594 RSUs will vest on February 14, 2020; and 3,640 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:41 UTC
Lagano RoxanneExecutive Vice President
GrantPerformance Award Unit · Derivative 6,746.5982 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000061 · wf-form4_151873085909935.xml · derivative · entry 3

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,746.5982

Underlying: Common Stock · 6,746.5982 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2015-2017 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 13, 2018, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:41 UTC
Lagano RoxanneExecutive Vice President
GrantStock Option · Derivative 13,964 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000061 · wf-form4_151873085909935.xml · derivative · entry 2

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 141,776

Underlying: Common Stock · 13,964 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 35,663 options granted January 31, 2013 at an exercise price of $26.00 per option; 37,453 options granted March 4, 2014 at an exercise price of $30.89 per option; 17,852 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; and 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 35,663 options granted January 31, 2013 at an exercise price of $26.00 per option; 37,453 options granted March 4, 2014 at an exercise price of $30.89 per option; 17,852 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; and 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:41 UTC
Lagano RoxanneExecutive Vice President
GrantRestricted Stock Unit · Derivative 3,868 $73.24 $283,292.32
Disclosure

SEC source: 0001555280-18-000061 · wf-form4_151873085909935.xml · derivative · entry 1

Lagano Roxanne · CIK 0001567878 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,319.7516

Underlying: Common Stock · 3,868 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 4,621.7982 RSUs will vest on February 27, 2018; 5,255.8174 RSUs will vest on February 19, 2019; 4,574.1360 RSUs will vest on February 14, 2020; and 3,868 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:48 UTC
Lewis Clinton A. Jr.Executive Vice President
GrantPerformance Award Unit · Derivative 10,795.7844 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000062 · wf-form4_151873094233746.xml · derivative · entry 3

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,795.7844

Underlying: Common Stock · 10,795.7844 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2015-2017 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 13, 2018, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:48 UTC
Lewis Clinton A. Jr.Executive Vice President
GrantStock Option · Derivative 24,642 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000062 · wf-form4_151873094233746.xml · derivative · entry 2

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,197

Underlying: Common Stock · 24,642 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. Each option vests on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 42,796 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 42,796 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 35,746 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:48 UTC
Lewis Clinton A. Jr.Executive Vice President
GrantRestricted Stock Unit · Derivative 6,826 $73.24 $499,936.24
Disclosure

SEC source: 0001555280-18-000062 · wf-form4_151873094233746.xml · derivative · entry 1

Lewis Clinton A. Jr. · CIK 0001567831 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,463.8307

Underlying: Common Stock · 6,826 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 7,394.8771 RSUs will vest on February 27, 2018; 9,703.8279 RSUs will vest on February 19, 2019; 8,539.1257 RSUs will vest on February 14, 2020; and 6,826 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:38 UTC
Knupp Catherine A.Executive Vice President
GrantPerformance Award Unit · Derivative 10,795.7844 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000059 · wf-form4_151873068732376.xml · derivative · entry 3

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,795.7844

Underlying: Common Stock · 10,795.7844 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2015-2017 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 13, 2018, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:38 UTC
Knupp Catherine A.Executive Vice President
GrantStock Option · Derivative 24,642 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000059 · wf-form4_151873068732376.xml · derivative · entry 2

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,218

Underlying: Common Stock · 24,642 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 42,796 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 32,767 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 42,796 options granted January 31, 2013 at an exercise price of $26.00 per option; 46,816 options granted March 4, 2014 at an exercise price of $30.89 per option; 28,563 options granted February 27, 2015 at an exercise price of $46.09 per option; 32,767 options granted February 19, 2016 at an exercise price of $41.83 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 24,642 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:38 UTC
Knupp Catherine A.Executive Vice President
GrantRestricted Stock Unit · Derivative 6,826 $73.24 $499,936.24
Disclosure

SEC source: 0001555280-18-000059 · wf-form4_151873068732376.xml · derivative · entry 1

Knupp Catherine A. · CIK 0001567826 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,655.0095

Underlying: Common Stock · 6,826 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 7,394.8771 RSUs will vest on February 27, 2018; 8,895.0067 RSUs will vest on February 19, 2019; 8,539.1257 RSUs will vest on February 14, 2020; and 6,826 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:36 UTC
David GlennChief Financial Officer
GrantPerformance Award Unit · Derivative 2,914.187 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000058 · wf-form4_151873058236829.xml · derivative · entry 3

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,914.187

Underlying: Common Stock · 2,914.187 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2015-2017 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 13, 2018, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:36 UTC
David GlennChief Financial Officer
GrantStock Option · Derivative 26,285 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000058 · wf-form4_151873058236829.xml · derivative · entry 2

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,652

Underlying: Common Stock · 26,285 shares

Expires not disclosed

F6 · security: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.

F7 · derivative.exercise_price: 16,385 options granted March 4, 2014 at an exercise price of $30.89 per option; 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 8,191 options granted February 19, 2016 at an exercise price of $41.83; 21,301 options granted August 22, 2016 at an exercise price of $51.23 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option.

F8 · derivative.exercise_date: Each option vests on the third anniversary of the date of grant.

F9 · derivative.expiration_date: Each option expires on the tenth anniversary of the date of grant.

F7 · balance_after: 16,385 options granted March 4, 2014 at an exercise price of $30.89 per option; 7,712 options granted February 27, 2015 at an exercise price of $46.09 per option; 8,191 options granted February 19, 2016 at an exercise price of $41.83; 21,301 options granted August 22, 2016 at an exercise price of $51.23 per option; 11,144 options granted December 6, 2016 at an exercise price of $50.22 per option; 32,634 options granted February 14, 2017 at an exercise price of $55.02 per option; and 26,285 options granted February 13, 2018 at an exercise price of $73.24 per option.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:36 UTC
David GlennChief Financial Officer
GrantRestricted Stock Unit · Derivative 7,281 $73.24 $533,260.44
Disclosure

SEC source: 0001555280-18-000058 · wf-form4_151873058236829.xml · derivative · entry 1

David Glenn · CIK 0001606256 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,476.7046

Underlying: Common Stock · 7,281 shares

Expires not disclosed

F1 · security: Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

F3 · derivative.exercise_date: Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

F5 · balance_after: The RSUs vest as follows: 1,995.9625 RSUs will vest on February 27, 2018; 2,223.4980 RSUs will vest on February 19, 2019; 5,424.8044 RSUs will vest on August 22, 2019; 3,012.3140 RSUs will vest on December 6, 2019; 8,539.1257 RSUs will vest on February 14, 2020; and 7,281 RSUs will vest on February 13, 2021.

Read SEC document
February 13, 2018 Filed Feb 15, 2018 21:35 UTC
Chen Heidi C.Executive Vice President
GrantPerformance Award Unit · Derivative 8,636.2186 $0.00 $0.00
Disclosure

SEC source: 0001555280-18-000057 · wf-form4_151873050821813.xml · derivative · entry 3

Chen Heidi C. · CIK 0001567828 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,636.2186

Underlying: Common Stock · 8,636.2186 shares

Expires not disclosed

F10 · security: Represents performance award units with a three-year performance period covering 2015-2017 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 13, 2018, which is the date the Zoetis Compensation Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F11 · derivative.exercise_price: Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.

F12 · derivative.exercise_date: Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 27, 2018, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

F4 · derivative.expiration_date: Not applicable.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.